Novacor upgrade
This article was originally published in The Gray Sheet
Executive Summary
WorldHeart will begin shipping an upgraded version of the left-ventricular assist device in the U.S. and Canada by the end of March, the company notes in a Jan. 7 release announcing FDA approval of the enhancements. Already approved in Canada and Europe, improvements include quieter pump operation, a smaller, longer-lasting battery and a smaller, quieter battery charger, according to the firm. Novacor is FDA-approved as a bridge to transplant, and will be the subject of a 250 to 300-patient destination therapy trial this year (1"The Gray Sheet" Nov. 10, 2003, p. 39)...